Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology 3/2020
memo - Magazine of European Medical Oncology

Ausgabe 3/2020

share
TEILEN
insite
SUCHEN

Inhaltsverzeichnis (26 Artikel)

01.09.2020 | editorial

Creating the “new normal” post-Coronavirus world—web-communication replacing face-to-face interaction
Wolfgang Hilbe, Andreas Pircher, Thorsten Füreder, Holger Rumpold, Eberhard Gunsilius, Rupert Bartsch

01.09.2020 | editorial

News from ASH 2019
Eberhard Gunsilius

01.09.2020 | editorial

Treatment of advanced melanoma
Van Anh Nguyen

01.09.2020 | editorial

Rectal cancer: latest developments and innovative new treatment concepts
Arno Amann

01.09.2020 | editorial

Therapies in flux: highlights of the 2019 San Antonio Breast Cancer Symposium (SABCS)
Simon Peter Gampenrieder

01.09.2020 | editorial

Managing an oncology clinic during the COVID-19 pandemic—how we did it in Sarajevo?
Semir Beslija

31.08.2020 | editorial

memo—publisher’s report 2019
Alois Sillaber

Open Access 19.05.2020 | short review

Fine-tuning front-line therapy in chronic lymphocytic leukemia
News from ASH 2019
Jan-Paul Bohn, Dominik Wolf

Open Access 20.05.2020 | short review

ASH highlights 2019: “aggressive B-cell lymphoma”
Clemens A. Schmitt

13.05.2020 | short review

Highlights of ASH 2019—multiple myeloma
Heinz Ludwig

26.05.2020 | short review

Myeloid diseases—Chronic Myeloid Leukemia (CML)—report from ASH 2019 on new developments
Andreas L. Petzer

Open Access 20.05.2020 | short review

New systemic treatment options in mycosis fungoides and Sézary syndrome
Magdalena Seidl-Philipp, Van Anh Nguyen

Open Access 03.07.2020 | review

Patient-reported outcomes and psycho-oncological screening in hematology: a practical example of routine electronic monitoring
Jens Lehmann, Lisa M. Wintner, Monika Sztankay, Wolfgang Willenbacher, Roman Weger, Walpurga Weyrer, Gerhard Rumpold, Bernhard Holzner

25.05.2020 | original report

Comparison of outcomes of two non-BCNU-containing conditioning regimens used in autologous stem cell transplantation for relapsed/refractory lymphoma
Amro Mohamed Sedky El-Ghammaz, Maha El-Zimaity, Afaf Abdel-Aziz Abdel-Ghaffar

Open Access 15.04.2020 | short review

Adjuvant and neoadjuvant treatment of melanoma
Peter Koelblinger

Open Access 15.04.2020 | short review

The therapeutic landscape of advanced melanoma
Erika Richtig

Open Access 14.08.2020 | short review

The future of combination therapies in advanced melanoma
Christoph Hoeller

26.05.2020 | original report

Rectal cancer among younger Egyptian patients—clinico-pathological features and oncologic outcomes: A single institution experience
Amir M. Zaid, Engy M. Aboelnaga, Amal Halim, Mohamed Abdelkhalek, Saleh S. Elbalka, Mohamed Zuhdy, Ahmed M. Fareed, Eman M. Ibrahim, Hosam Halim, Islam H. Metwally

13.03.2020 | short review

Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer
Which way to go?
Fabian Lunger, Georgios Peros

Open Access 15.04.2020 | short review

Neoadjuvant chemoradiotherapy in rectal cancer
Are there new drug combinations on the horizon?
Christoph Reinhold Arnold, Julian Mangesius, Robert Jäger, Ute Ganswindt

16.04.2020 | short review

Circulating tumour DNA-guided adjuvant chemotherapy in colorectal carcinoma
Andreas Reichinger, Holger Rumpold

30.06.2020 | case report

Four lines of immunochemotherapy combinations in a young patient with an aggressive metastatic colorectal cancer
Frédéric H. Witte, Wolfgang Hilbe, Ercan Müldür

13.07.2020 | short review

San Antonio Breast Cancer Symposium 2019: human epidermal growth factor receptor 2(HER2)-positive breast cancer and image-guided biopsy to detect pathologic complete response (pCR)
Clemens Dormann

Open Access 07.05.2020 | short review

Treatment options in early triple-negative breast cancer
Update from the San Antonio Breast Cancer Symposium 2019
Christoph Suppan, Marija Balic

Open Access 01.09.2020 | short review

San Antonio 2019: interesting topics for daily clinical practice in breast cancer
Arik Galid

25.05.2020 | original report

Biologically effective dose and overall survival in stereotactic body radiotherapy for lung tumors
Osamu Tanaka, Norihiko Funaguchi, Sayaka Toyoshi, Takuya Taniguchi, Kousei Ono, Chiyoko Makita, Masayuki Matsuo

Aktuelle Ausgaben